Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. - Wikidata - awgldk - TriplyDB

Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review.

Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review.

http://www.wikidata.org/entity/Q34207210

about

Small intestine bleeding due to multifocal angiosarcoma Primary breast angiosarcoma: avoiding a common trap Systemic therapy in primary angiosarcoma of the spleen.Littoral cell angioma and angiosarcoma of the spleen: report of two cases in siblings and review of the literature.Obscure gastrointestinal bleeding due to multifocal intestinal angiosarcoma.Splenic Angiosarcoma: A Diagnostic Splenectomy Finding.Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.

P2860

Q28391476-60F7B3C0-B64E-418B-AEFA-605F81E83CBE Q35952843-50D0B952-5FE0-4ED8-8A80-24B643D9C2ED Q36569362-0D15B62A-FE3E-4BAA-8E5B-D731B4F34D16 Q37954168-B905E247-9DE4-4C0E-B25F-13C4FB98FF53 Q40625242-93807D3D-3054-47D3-9AF8-0FC661FEB443 Q42362430-CBC31FF6-1DBB-4EE6-872D-10018C6574AD Q45180255-64346C18-7BE2-4BC6-B608-7680A04579F6 Q54729658-50D317C5-51AF-4514-AA3B-D7EC4D7B8478

P2860

Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review.

http://www.wikidata.org/entity/Q34207210

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Paclitaxel as neoadjuvant ther ...... report and literature review.

@ast

Paclitaxel as neoadjuvant ther ...... report and literature review.

@en

Paclitaxel as neoadjuvant ther ...... report and literature review.

@nl

type

label

Paclitaxel as neoadjuvant ther ...... report and literature review.

@ast

Paclitaxel as neoadjuvant ther ...... report and literature review.

@en

Paclitaxel as neoadjuvant ther ...... report and literature review.

@nl

prefLabel

Paclitaxel as neoadjuvant ther ...... report and literature review.

@ast

Paclitaxel as neoadjuvant ther ...... report and literature review.

@en

Paclitaxel as neoadjuvant ther ...... report and literature review.

@nl

P1433

Q34207210-12FB24C9-B108-492B-929D-E0ECF9D42958

P1476

Q34207210-5ABB0A1F-5A6B-4ED6-BE1A-069D205D2561

P2093

Q34207210-9345537F-5861-47D2-974A-2FF8A7AA3F95

P2860

Q34207210-02C5B4F2-BE42-432E-B514-BD561BF4A506

Q34207210-05647722-6A3D-49B4-9BB3-6242A42C967A

Q34207210-38E9DC46-AFCE-49AE-B7E5-BC1D533AF677

Q34207210-423FB35B-2E1D-42D8-815A-7782499BCF8C

Q34207210-487FCE8F-6B67-4C86-93C5-9D20379ECF9B

Q34207210-99367F0F-24DB-4425-87AB-3FE7D51E52B6

Q34207210-A34F7B92-5107-4F29-ABE4-4795D8542C68

Q34207210-A8AA9AFD-94CB-413E-8FDF-954AFF0AB422

Q34207210-ADD6FE7C-4D25-4EF0-BDAF-10558D800E1B

Q34207210-B3DEBB2A-21A3-424C-A0F7-785D4AE8577D

P304

Q34207210-1F36A5C6-7CB5-470E-86A9-A8D73E523A6B

P31

Q34207210-5F99A676-55FA-4D79-A4C6-35420A230C69

Q34207210-f103f6fb-a982-4a9f-8e73-738bf95ecdb0

P356

Q34207210-76F7CD02-08A3-4E31-938B-287E40A5AC96

P407

Q34207210-20902C79-2880-4B41-BD8A-9215DAAC779A

P478

Q34207210-4CAC27E0-3FA6-4C58-981F-E4F0ABA58428

P50

Q34207210-87C1C31D-C401-44B5-8742-7E6246DE03B2

P577

Q34207210-6D0B319A-87AD-4B15-80C7-670E0756EA81

P5875

Q34207210-5575E76C-69BB-4762-8AA5-CC9C8B4BC20A

P698

Q34207210-3E6D5873-9634-42A9-BD61-6AB705D100E4

P932

Q34207210-3DA1D50C-13F6-485E-837E-251837485D77

P356

P1433

Clinical Medicine: Oncology

P1476

Paclitaxel as neoadjuvant ther ...... f report and literature review

@en

P2093

Bhanu Vakkalanka

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.

Angiosarcoma of the spleen: imaging characteristics in 12 patients.

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere.

Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature.

Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.

Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases.

Phase II trial of paclitaxel in patients with soft-tissue sarcoma.

P304

107-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMO.S5329

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47567079

http://www.w3.org/2001/XMLSchema#string

P698

20981134

http://www.w3.org/2001/XMLSchema#string

P932

2956477

http://www.w3.org/2001/XMLSchema#string